|
1
|
Taga T, Tomizawa D, Takahashi H and Adachi
S: Acute myeloid leukemia in children: Current status and future
directions. Pediatr Int. 58:71–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kadia TM, Ravandi F, Cortes J and
Kantarjian H: New drugs in acute myeloid leukemia. Ann Oncol.
27:770–778. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Döhner H, Estey EH, Amadori S, Appelbaum
FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson
RA, et al: Diagnosis and management of acute myeloid leukemia in
adults: Recommendations from an international expert panel, on
behalf of the European LeukemiaNet. Blood. 115:453–474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burnett A, Wetzler M and Löwenberg B:
Therapeutic advances in acute myeloid leukemia. J Clin Oncol.
29:487–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marcucci G, Haferlach T and Döhner H:
Molecular genetics of adult acute myeloid leukemia: Prognostic and
therapeutic implications. J Clin Oncol. 29:475–486. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meyer SC and Levine RL: Translational
implications of somatic genomics in acute myeloid leukaemia. Lancet
Oncol. 15:e382–e394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network. Ley
TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley
K, Triche TJ Jr, Laird PW, et al: Genomic and epigenomic landscapes
of adult de novo acute myeloid leukemia. N Engl J Med.
368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding L, Ley TJ, Larson DE, Miller CA,
Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan
MD, et al: Clonal evolution in relapsed acute myeloid leukaemia
revealed by whole-genome sequencing. Nature. 481:506–510. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roboz GJ: Current treatment of acute
myeloid leukemia. Curr Opin Oncol. 24:711–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang ES: Treating acute myeloid leukemia
in older adults. Hematology Am Soc Hematol Educ Program.
2014:14–20. 2014.PubMed/NCBI
|
|
12
|
Curran MP: Decitabine: A review of its use
in older patients with acute myeloid leukaemia. Drugs Aging.
30:447–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klco JM, Spencer DH, Lamprecht TL,
Sarkaria SM, Wylie T, Magrini V, Hundal J, Walker J, Varghese N,
Erdmann-Gilmore P, et al: Genomic impact of transient low-dose
decitabine treatment on primary AML cells. Blood. 121:1633–1643.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Durinck S, Spellman PT, Birney E and Huber
W: Mapping identifiers for the integration of genomic datasets with
the R/Bioconductor package biomaRt. Nat Protoc. 4:1184–1191. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article32004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang D, Yan L, Hu Q, Sucheston LE, Higgins
MJ, Ambrosone CB, Johnson CS, Smiraglia DJ and Liu S: IMA: An R
package for high-throughput analysis of Illumina's 450K Infinium
methylation data. Bioinformatics. 28:729–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sherman BT, da Huang W, Tan Q, Guo Y, Bour
S, Liu D, Stephens R, Baseler MW, Lane HC and Lempicki RA: DAVID
Knowledgebase: A gene-centered database integrating heterogeneous
gene annotation resources to facilitate high-throughput gene
functional analysis. BMC Bioinformatics. 8:4262007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Daskalakis M, Blagitko-Dorfs N and
Hackanson B: Decitabine. Small Molecules in Oncology Berlin
Heidelberg: Springer; pp. 131–157. 2010, View Article : Google Scholar
|
|
21
|
Flotho C, Claus R, Batz C, Schneider M,
Sandrock I, Ihde S, Plass C, Niemeyer CM and Lübbert M: The DNA
methyltransferase inhibitors azacitidine, decitabine and zebularine
exert differential effects on cancer gene expression in acute
myeloid leukemia cells. Leukemia. 23:1019–1028. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Löwenberg B: Sense and nonsense of
high-dose cytarabine for acute myeloid leukemia. Blood. 121:26–28.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Momparler RL: Optimization of cytarabine
(ARA-C) therapy for acute myeloid leukemia. Exp Hematol Oncol.
2:202013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu S, Wan J, Su Y, Song Q, Zeng Y, Nguyen
HN, Shin J, Cox E, Rho HS, Woodard C, et al: DNA methylation
presents distinct binding sites for human transcription factors.
Elife. 2:e007262013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Egger G, Liang G, Aparicio A and Jones PA:
Epigenetics in human disease and prospects for epigenetic therapy.
Nature. 429:457–463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Robertson KD: DNA methylation and human
disease. Nat Rev Genet. 6:597–610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feinberg AP: Phenotypic plasticity and the
epigenetics of human disease. Nature. 447:433–440. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Reik W: Stability and flexibility of
epigenetic gene regulation in mammalian development. Nature.
447:425–432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weaver IC, Hellstrom IC, Brown SE, Andrews
SD, Dymov S, Diorio J, Zhang TY, Szyf M and Meaney MJ: The
methylated-DNA binding protein MBD2 enhances NGFI-A
(egr-1)-mediated transcriptional activation of the glucocorticoid
receptor. Philos Trans R Soc Lond B Biol Sci. 369:pii: 20130513.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robertson KD and Wolffe AP: DNA
methylation in health and disease. Nat Rev Genet. 1:11–19. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu Y, Liu F, Lin IY, Gao GF and Zhu B:
Dissemination of the mcr-1 colistin resistance gene. Lancet Infect
Dis. 16:146–147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lewis JD, Meehan RR, Henzel WJ,
Maurer-Fogy I, Jeppesen P, Klein F and Bird A: Purification,
sequence, and cellular localization of a novel chromosomal protein
that binds to methylated DNA. Cell. 69:905–914. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Weber M, Davies JJ, Wittig D, Oakeley EJ,
Haase M, Lam WL and Schübeler D: Chromosome-wide and
promoter-specific analyses identify sites of differential DNA
methylation in normal and transformed human cells. Nat Genet.
37:853–862. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cokus SJ, Feng S, Zhang X, Chen Z,
Merriman B, Haudenschild CD, Pradhan S, Nelson SF, Pellegrini M and
Jacobsen SE: Shotgun bisulphite sequencing of the Arabidopsis
genome reveals DNA methylation patterning. Nature. 452:215–219.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nestheide S, Bridge JA, Barnes M, Frayer R
and Sumegi J: Pharmacologic inhibition of epigenetic modification
reveals targets of aberrant promoter methylation in Ewing sarcoma.
Pediatr Blood Cancer. 60:1437–1446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ben Abdelali R, Roggy A, Leguay T, Cieslak
A, Renneville A, Touzart A, Banos A, Randriamalala E, Caillot D,
Lioure B, et al: SET-NUP214 is a recurrent γδ lineage-specific
fusion transcript associated with corticosteroid/chemotherapy
resistance in adult T-ALL. Blood. 123:1860–1863. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Manodoro F, Marzec J, Chaplin T,
Miraki-Moud F, Moravcsik E, Jovanovic JV, Wang J, Iqbal S, Taussig
D, Grimwade D, et al: Loss of imprinting at the 14q32 domain is
associated with microRNA overexpression in acute promyelocytic
leukemia. Blood. 123:2066–2074. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Buchi F, Spinelli E, Masala E, Gozzini A,
Sanna A, Bosi A, Ferrari G and Santini V: Proteomic analysis
identifies differentially expressed proteins in AML1/ETO acute
myeloid leukemia cells treated with DNMT inhibitors azacitidine and
decitabine. Leuk Res. 36:607–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
